Becton, Dickinson and Company (BDX)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 246.53 |
| Open | 246.50 |
| Bid | 251.41 x 800 |
| Ask | 259.82 x 800 |
| Day's range | 244.32 - 252.16 |
| 52-week range | 229.40 - 277.29 |
| Volume | |
| Avg. volume | 1,152,824 |
| Market cap | 71.779B |
| Beta (5Y monthly) | 0.66 |
| PE ratio (TTM) | 39.65 |
| EPS (TTM) | 6.35 |
| Earnings date | 03 Aug 2022 - 08 Aug 2022 |
| Forward dividend & yield | 3.48 (1.38%) |
| Ex-dividend date | 08 Jun 2022 |
| 1y target est | 280.91 |
- Zacks
BD's (BDX) New Combination Test to Boost Patient Outcome
BD's (BDX) latest combination test is expected to speed up the detection of the infection-causing viruses, thereby accelerating the implementation of the appropriate treatment plan.
- Zacks
BD (BDX) Integrates Innovative Solution to Boost Patient Care
BD's (BDX) announcement of the implementation of BD HealthSight brings together timely monitoring to support the early detection of emerging healthcare infections, thereby improving patient care.
- Zacks
BD's (BDX) Latest Collaboration to Enhance Patient Care
BD's (BDX) new partnership is expected to increase efficiency for new clinical trials, generate evidence, support new claims for its products and streamline medical device regulatory submissions.
© 2022 Yahoo. All rights reserved.
